Zobrazeno 1 - 10
of 595
pro vyhledávání: '"Christos, Chouaid"'
Autor:
Simon Nannini, Florian Guisier, Hubert Curcio, Charles Ricordel, Pierre Demontrond, Safa Abdallahoui, Seyyid Baloglu, Laurent Greillier, Christos Chouaid, Roland Schott
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1656-1666 (2024)
Non-small cell lung cancer (NSCLC) is the most common cause of brain metastasis (BM). Little is known about immune checkpoint inhibitor activity in the central nervous system, especially in patients receiving monotherapy for tumors with a tumor propo
Externí odkaz:
https://doaj.org/article/12578945492840c0b16d19f635987c77
Autor:
Francesca Lucibello, MD, Valérie Gounant, MD, PhD, Mihaela Aldea, MD, PhD, Michaël Duruisseaux, MD, PhD, Maurice Perol, MD, Christos Chouaid, MD, Jaafar Bennouna, MD, PhD, Vincent Fallet, MD, Aldo Renault, MD, Florian Guisier, MD, PhD, Etienne Giroux-Leprieur, MD, PhD, Marie Wislez, MD, PhD, Anne-Claire Toffart, MD, PhD, Julien Mazieres, MD, PhD, Clémence Basse, MD, PhD, Nadia Hegarat, PhD, Matthieu Carton, MD, Nicolas Girard, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 6, Iss 1, Pp 100743- (2025)
Introduction: Pralsetinib is a RET inhibitor found to have antitumor activity in advanced, metastatic, RET fusion-positive NSCLC. Objective: To assess real-world efficacy of pralsetinib and treatment sequences in patients with RET fusion-positive NSC
Externí odkaz:
https://doaj.org/article/0c41f917b5ca448d96c9f58872859bd4
Autor:
Hélène Pluchart, Sébastien Chanoine, Denis Moro-Sibilot, Christos Chouaid, Gil Frey, Julie Villa, Bruno Degano, Matteo Giaj Levra, Pierrick Bedouch, Anne-Claire Toffart
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2024)
Most patients with lung cancer are smokers and are of advanced age. They are therefore at high risk of having age- and lifestyle-related comorbidities. These comorbidities are subject to treatment or even polypharmacy. There is growing evidence of a
Externí odkaz:
https://doaj.org/article/bb23e6f3c8cf4b5998347bf1f9f10caa
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 641-658 (2022)
The ROS-1 gene plays a major role in the oncogenesis of numerous tumors. ROS-1 rearrangement is found in 0.9–2.6% of non-small-cell lung cancers (NSCLCs), mostly lung adenocarcinomas, with a significantly higher rate of women, non-smokers, and a te
Externí odkaz:
https://doaj.org/article/b40669e4029f44fd845e1fa715f1ab44
Autor:
Isabelle Martel-Lafay, Isabelle Monnet, Audrey Lardy-Cleaud, Serge Danhier, Naji Salem, Olivier Gallocher, Pierre Fournel, Christos Chouaid, Olivier Bylicki, the GFPC 01-14 Investigators
Publikováno v:
Current Oncology, Vol 28, Iss 5, Pp 3804-3811 (2021)
Concomitant radiochemotherapy (RTCT) is the standard treatment for unresectable stage III non-small cell lung cancer (NSCLC). However, in patients with a peripheral primary tumor, the irradiated volume may include a large portion of normal lung and R
Externí odkaz:
https://doaj.org/article/be142ede26be42bfa1d3c551b649c2ed
Autor:
Margaux Geier, Renaud Descourt, Romain Corre, Guillaume Léveiller, Régine Lamy, Éric Goarant, Jean‐Louis Bizec, Cyril Bernier, Gilles Quéré, Karim Amrane, Elisabeth Gaye, François Lucia, Emilie Burte, Christos Chouaid, Gilles Robinet
Publikováno v:
Cancer Medicine, Vol 9, Iss 19, Pp 6923-6932 (2020)
Abstract Background A standard of care for pretreated, advanced non–small‐cell lung cancers (NSCLCs), nivolumab has demonstrated long‐term benefit when administered for 2 years. We aimed to better discern an optimized administration duration by
Externí odkaz:
https://doaj.org/article/b2ddd64664b94102b1cc3e3c92911bf0
Autor:
Karim Amrane, Margaux Geier, Romain Corre, Hervé Léna, Guillaume Léveiller, Florence Gadby, Régine Lamy, Jean‐Louis Bizec, Eric Goarant, Gilles Robinet, Sylvie Gouva, Gilles Quere, Ronan Abgral, Ulrike Schick, Cyril Bernier, Christos Chouaid, Renaud Descourt
Publikováno v:
Cancer Medicine, Vol 9, Iss 7, Pp 2309-2316 (2020)
Abstract Background The KEYNOTE‐024 trial demonstrated that pembrolizumab, a PD‐1 inhibitor, significantly improves progression‐free survival (PFS) and overall survival (OS) in selected patients with previously untreated advanced non–small ce
Externí odkaz:
https://doaj.org/article/c98d4e070de24144a3c13472f5f9c857
Autor:
Camille Jung, Jean-Baptiste Excoffier, Mathilde Raphaël-Rousseau, Noémie Salaün-Penquer, Matthieu Ortala, Christos Chouaid
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263266 (2022)
Characteristics of patients at risk of developing severe forms of COVID-19 disease have been widely described, but very few studies describe their evolution through the following waves. Data was collected retrospectively from a prospectively maintain
Externí odkaz:
https://doaj.org/article/2498146253a145eaa3c1447f2ebe24bf
Autor:
Manon Kissel, Isabelle Martel-Lafay, Justine Lequesne, Jean-Christophe Faivre, Cécile Le Péchoux, Dinu Stefan, Victor Barraux, Cédric Loiseau, Jean-Michel Grellard, Serge Danhier, Delphine Lerouge, Christos Chouaid, Radj Gervais, Juliette Thariat
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Stereotactic irradiation (SBRT) is a standard of care for inoperable stage I lung cancer and brain oligometastases from lung cancer but is controversial for extracranial oligometastases. We assessed outcomes of lung cancer patient
Externí odkaz:
https://doaj.org/article/efaf790b07914692a240956c6f976948
Autor:
Alice Guyard, Cécile Charpy, Nathalie Théou-Anton, Anne Cremades, Frédéric Grassin, Anaïs Bourgogne, Karen Leroy, Anaïs Pujals, Christiane Copie-Bergman, Christos Chouaid, Audrey Mansuet-Lupo
Publikováno v:
Translational Oncology, Vol 12, Iss 5, Pp 784-787 (2019)
Anaplastic lymphoma kinase (ALK) rearrangement is reported in 3% to 8% of patients with lung adenocarcinoma and can be detected by fluorescent in situ hybridization (FISH) or indirectly by immunohistochemistry. In FISH assay, isolated 5′ signal (lo
Externí odkaz:
https://doaj.org/article/417e1885bac74146a6c2267bde74831b